External device review pilot should await amendments to device law, NEMA says.
This article was originally published in The Gray Sheet
Executive Summary
THIRD-PARTY DEVICE REVIEW PROGRAM SHOULD LIMIT FDA ROLE TO OVERSIGHT, Robert Britain, head of the National Electrical Manufacturers Association's diagnostic imaging and therapy systems division said at a June 19 workshop in Rockville, Maryland. "Final approval authority for new products should rest with accredited third-party reviewers, rather than with FDA itself," Britain stated.You may also be interested in...
Vemedia Acquires GSK Brands In Italy, Strikes Deal For GI Product In Spain
EU Preserves Status Quo On Drugs Under Additional Monitoring
The European Commission has set aside, for now, concerns expressed by member states regarding the scope of medicines subjected to additional monitoring requirements.
Meitheal Gets US Enoxaparin Approval
Through its partnership with majority stakeholder Nanjing King-Friend Biochemical Pharmaceutical, Meitheal Pharmaceuticals has received FDA approval for enoxaparin, a generic rival to Lovenox.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: